Top Markets
Coin of the day
Cadrenal Therapeutics, Inc. Common Stock Cadrenal Therapeutics, Inc. Common Stock

Cadrenal Therapeutics, Inc. Common Stock

CVKD
Classement en actions #33958
Cadrenal Therapeutics, Inc. operates as a biopharmaceutical enterprise... Cadrenal Therapeutics, Inc. operates as a biopharmaceutical enterprise primarily engaged in clinical development. The company's core focus is the advancement of Tecarfarin, a novel therapeutic agent that has received orphan drug designation. This treatment is engineered to prevent systemic thromboembolism originating from cardiac issues in patients suffering from both end-stage renal disease and atrial fibrillation. Established in 2022, the firm is headquartered in Ponte Vedra, Florida.
Prix de l'action
$1.83
Dernière synchronisation: 2026-08-14
Capitalisation boursière
$6.53M
Changement (1 jour)
-1.61%
Changement (1 an)
-85.57%
Pays
US
Échange Cadrenal Therapeutics, Inc. Common Stock (CVKD)

Catégorie

Historique du prix de l'action pour Cadrenal Therapeutics, Inc. Common Stock (CVKD)
Prix de clôture le plus élevé : $1.89 le 2026-08-01

Prix de clôture le plus bas : $46.78 le 2023-01-01
Historique du prix de l'action de Cadrenal Therapeutics, Inc. Common Stock de 2023 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) -11.31%
2025 -35.19%
2024 69.00%
2023 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE